Deutsche Bank AG Lowers Stake in Stevanato Group S.p.A. (NYSE:STVN)

Deutsche Bank AG cut its position in shares of Stevanato Group S.p.A. (NYSE:STVN - Free Report) by 20.5% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 989,661 shares of the company's stock after selling 255,952 shares during the quarter. Deutsche Bank AG owned about 0.33% of Stevanato Group worth $21,565,000 at the end of the most recent quarter.

Other large investors also recently modified their holdings of the company. TimesSquare Capital Management LLC increased its position in Stevanato Group by 114.6% during the 4th quarter. TimesSquare Capital Management LLC now owns 3,288,529 shares of the company's stock worth $71,657,000 after purchasing an additional 1,756,100 shares in the last quarter. Jennison Associates LLC purchased a new stake in Stevanato Group during the fourth quarter worth approximately $20,239,000. Mutual of America Capital Management LLC acquired a new stake in shares of Stevanato Group in the fourth quarter worth $13,848,000. Ranger Investment Management L.P. purchased a new position in shares of Stevanato Group in the 4th quarter valued at $12,940,000. Finally, Artisan Partners Limited Partnership lifted its holdings in shares of Stevanato Group by 28.7% during the 4th quarter. Artisan Partners Limited Partnership now owns 2,355,799 shares of the company's stock valued at $51,333,000 after acquiring an additional 524,989 shares in the last quarter.

Wall Street Analysts Forecast Growth

Several analysts recently issued reports on the company. William Blair reiterated an "outperform" rating on shares of Stevanato Group in a report on Friday, March 7th. Stephens upgraded Stevanato Group to a "strong-buy" rating in a report on Monday, April 21st. Finally, UBS Group decreased their price target on Stevanato Group from $24.00 to $23.50 and set a "neutral" rating for the company in a report on Friday, March 7th. Two equities research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average price target of €25.70 ($28.88).

Stevanato Group Stock Performance

NYSE:STVN opened at €23.76 ($26.70) on Thursday. The firm has a 50-day moving average of €21.34 and a two-hundred day moving average of €21.12. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.81 and a quick ratio of 1.21. The stock has a market cap of $7.20 billion, a P/E ratio of 50.55, a PEG ratio of 7.18 and a beta of 0.51. Stevanato Group S.p.A. has a 1-year low of €16.56 ($18.61) and a 1-year high of €24.96 ($28.04).

Stevanato Group (NYSE:STVN - Get Free Report) last released its quarterly earnings results on Thursday, March 6th. The company reported €0.20 ($0.22) EPS for the quarter, hitting the consensus estimate of €0.20 ($0.22). Stevanato Group had a return on equity of 9.86% and a net margin of 10.47%. The business had revenue of €352.68 million for the quarter, compared to analysts' expectations of €346.26 million. On average, research analysts expect that Stevanato Group S.p.A. will post 0.5 earnings per share for the current fiscal year.

Stevanato Group Increases Dividend

The business also recently declared an annual dividend, which will be paid on Thursday, July 17th. Stockholders of record on Thursday, June 5th will be given a dividend of $0.0613 per share. The ex-dividend date is Thursday, June 5th. This represents a dividend yield of 0.3%. This is an increase from Stevanato Group's previous annual dividend of $0.05. Stevanato Group's dividend payout ratio (DPR) is presently 11.76%.

Stevanato Group Company Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.

Want to see what other hedge funds are holding STVN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stevanato Group S.p.A. (NYSE:STVN - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.